Your browser doesn't support javascript.
loading
Split intein-mediated selection of cells containing two plasmids using a single antibiotic.
Palanisamy, Navaneethan; Degen, Anna; Morath, Anna; Ballestin Ballestin, Jara; Juraske, Claudia; Öztürk, Mehmet Ali; Sprenger, Georg A; Youn, Jung-Won; Schamel, Wolfgang W; Di Ventura, Barbara.
Afiliação
  • Palanisamy N; Signalling Research Centres BIOSS and CIBSS, University of Freiburg, 79104, Freiburg, Germany.
  • Degen A; Institute of Biology II, Faculty of Biology, University of Freiburg, 79104, Freiburg, Germany.
  • Morath A; Heidelberg Biosciences International Graduate School (HBIGS), 69120, Heidelberg, Germany.
  • Ballestin Ballestin J; Institute of Biology II, Faculty of Biology, University of Freiburg, 79104, Freiburg, Germany.
  • Juraske C; BioQuant Center for Quantitative Biology, University of Heidelberg, 69120, Heidelberg, Germany.
  • Öztürk MA; DKFZ Graduate School, University of Heidelberg, 69120, Heidelberg, Germany.
  • Sprenger GA; Signalling Research Centres BIOSS and CIBSS, University of Freiburg, 79104, Freiburg, Germany.
  • Youn JW; Department of Immunology, Institute of Biology III, Faculty of Biology, University of Freiburg, 79104, Freiburg, Germany.
  • Schamel WW; Spemann Graduate School of Biology and Medicine (SGBM), University of Freiburg, 79104, Freiburg, Germany.
  • Di Ventura B; Center for Chronic Immunodeficiency (CCI), Medical Center Freiburg and Faculty of Medicine, University of Freiburg, 79104, Freiburg, Germany.
Nat Commun ; 10(1): 4967, 2019 10 31.
Article em En | MEDLINE | ID: mdl-31672972
ABSTRACT
To build or dissect complex pathways in bacteria and mammalian cells, it is often necessary to recur to at least two plasmids, for instance harboring orthogonal inducible promoters. Here we present SiMPl, a method based on rationally designed split enzymes and intein-mediated protein trans-splicing, allowing the selection of cells carrying two plasmids with a single antibiotic. We show that, compared to the traditional method based on two antibiotics, SiMPl increases the production of the antimicrobial non-ribosomal peptide indigoidine and the non-proteinogenic aromatic amino acid para-amino-L-phenylalanine from bacteria. Using a human T cell line, we employ SiMPl to obtain a highly pure population of cells double positive for the two chains of the T cell receptor, TCRα and TCRß, using a single antibiotic. SiMPl has profound implications for metabolic engineering and for constructing complex synthetic circuits in bacteria and mammalian cells.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plasmídeos / Bactérias / Linfócitos T / Receptores de Antígenos de Linfócitos T alfa-beta / Processamento de Proteína / Farmacorresistência Bacteriana / Inteínas / Engenharia Metabólica / Antibacterianos Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plasmídeos / Bactérias / Linfócitos T / Receptores de Antígenos de Linfócitos T alfa-beta / Processamento de Proteína / Farmacorresistência Bacteriana / Inteínas / Engenharia Metabólica / Antibacterianos Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article